MELISSA GAGLIARDI: Open Payments
NPI 1821531427 · PONTE VEDRA BEACH, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$710 in 34 payments from 13 companies in 2025. Trend: 2023 $1,489 · 2024 $1,212 · 2025 $710
Food & beverage: $662Education: $48
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 4 | $103 |
| Galderma Laboratories, L.P. | 4 | $99 |
| Regeneron Healthcare Solutions, Inc. | 4 | $73 |
| Arcutis Biotherapeutics, Inc. | 3 | $64 |
| ABBVIE INC. | 3 | $61 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 3 | $54 |
| E.R. Squibb & Sons, L.L.C. | 3 | $50 |
| Novartis Pharmaceuticals Corporation | 2 | $48 |
| LEO Pharma Inc. | 2 | $47 |
| Incyte Corporation | 2 | $33 |
Products named: TREMFYA, DUPIXENT, Zoryve, Cabtreo, Sotyktu, ADBRY, RINVOQ, NEMLUVIO.
Industry payments across FL — which companies pay providers there.
